Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEXTENZA for Pain and Inflammation Following Cataract Surgery
NCT05626478Phase 4Completed
- Start
- Jun 2023
- Primary completion
- Feb 2025
- Modality
- Implantable Devices, Implantable Hydrogels, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ozurdex in anterior uveitis (AU). Started Jun 2023; status: completed.
02
Drugs
ozurdex
03
Conditions
anterior uveitis (AU)
Beyond the preview
Go deeper on NCT05626478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05626478.